Total Utang marang Modal Virax Biolabs (VRAX)

VRAX (viraxbiolabs.com) - tandha merek perusahaan

The market trend for the total debt-to-equity ratio of Virax Biolabs Group (VRAX) is 0.05. The business relies on a global viral monitoring system that integrates diagnostics with digital biosecurity services. The company's resilience ensures stable demand for screening regardless of economic cycles. Management is currently optimizing internal processes, seeking to solidify success through large-scale government agreements.

VRAX: Rasio Utang marang Ekuitas viraxbiolabs.com 28.04.2023 - 31.10.2026

Rincian analitis perusahaan Virax Biolabs Corp (VRAX)

- rega lan prakiraan konsensus rega:
Bagan rega Virax Biolabs|VRAX - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Virax Biolabs|VRAX - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Virax Biolabs|VRAX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku viraxbiolabs.com|VRAX - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Virax Biolabs Group|VRAX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Virax Biolabs Group|VRAX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Virax Biolabs|VRAX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Virax Biolabs|Likuiditas cepet viraxbiolabs.com
- informasi bathi lan kelipatan valuasi:
VRAX - Asil keuangan resik
Analisis dhasar perusahaan:VRAX, Virax Biolabs
Barang utama Virax Biolabs Corp

For the long-term investor, the reliability of Virax Biolabs Group is determined by the balance between external liabilities and equity. This ratio measures the share of borrowed capital within the total liability structure, allowing for an assessment of financial stability via the current debt-to-equity load during the scaling of T-cell test production and the deployment of mobile laboratories in Asia.

Pesaing wigati

Utang marang Ekuitas Agilent|Rasio Total Utang marang Ekuitas Quest Diagnostics Inc. (DGX)|Total Utang marang Modal ILMN|EXAS - Utang marang Modal|Total Utang marang Modal RVTY (Revvity, Inc.)|BIO: Rasio Utang marang Ekuitas|Anbio - Total Utang marang Modal|SHC - Total Utang marang Modal|QuidelOrtho Corp (QDEL) - Utang marang Ekuitas|Rasio Utang marang Ekuitas OPK|CDNA (CareDx Inc) - Total Utang marang Modal|Total Utang marang Modal maravai.com|Utang marang Ekuitas Fulgent Genetics (FLGT)|Utang marang Ekuitas LAB (Standard BioTools Inc)|Cytek Bio - Rasio Total Utang marang Ekuitas|OraSure Corp (OSUR) - Utang marang Modal|XGN - Utang marang Ekuitas|Koefisien Total Utang marang Modal mdxhealth.com MDXH|LUCD: Total Utang marang Modal|PRE - Koefisien Total Utang marang Modal|Utang marang Ekuitas Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas PRPH (ProPhase Labs, Inc.)|Utang marang Ekuitas AIMD (ainos.com)|Total Utang marang Modal CODX (Co-Diagnostics)|Koefisien Total Utang marang Modal Heart Test Laboratories, Inc. (HSCS)|BMRA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CDIO (Cardio Diagnostics)|BJDX: Total Utang marang Modal|aspirawh.com (AWH) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas AXDX|Rasio Utang marang Ekuitas CNTG (Centogene NV)|Rasio Total Utang marang Ekuitas ENZ (Enzo Biochem, Inc.)|FRES (fresh2.co) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GENE (Genetic Technologies Limited)|23andme.com - Utang marang Ekuitas|Psychemedics Corporation - Total Utang marang Modal